Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection

被引:17
作者
Kim, H. [1 ]
Kim, H. H. [2 ,3 ]
Park, J. S. [4 ]
Shin, H. J. [2 ,3 ]
Cha, J. H. [2 ,3 ]
Chae, E. Y. [2 ,3 ]
Choi, W. J. [2 ,3 ]
机构
[1] Seoul Med Ctr, Dept Radiol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Radiol, Div Breast Radiol, Ulsan 680749, South Korea
[3] Univ Ulsan, Coll Med, Res Inst Radiol, Ulsan 680749, South Korea
[4] Hanyang Univ, Coll Med, Dept Radiol, Seoul 133791, South Korea
关键词
GD-DTPA; TUMOR; RECURRENCE; ENHANCEMENT; DIFFERENTIATION; MAMMOGRAPHY; DOXORUBICIN; PACLITAXEL; ACCURACY; SURVIVAL;
D O I
10.1259/bjr.20140142
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To evaluate the usefulness of MR computer-aided detection (CAD) in patients undergoing neoadjuvant chemotherapy for prediction of the pathological complete response of tumours. Methods: 148 patients with breast cancer (mean age, 47.3 years; range, 29-72 years) who underwent neoadjuvant chemotherapy were included in our study. They underwent MRI before and after neoadjuvant chemotherapy, and we reviewed the pathological result as the gold standard. The computer-generated kinetic features for each lesion were recorded, and the features analysed included "threshold enhancement" at 50% and 100% minimum thresholds; degree of initial peak enhancement; and enhancement profiles comprising lesion percentages of washout, plateau and persistent enhancement. The final pathological size and character of tumours were correlated with post-chemotherapy mammography, ultrasonography and MR CAD findings. Kruskal-Wallis test and intraclass correlation coefficient were used to analyse the findings. Results: We divided the 148 patients into complete pathological response and non-complete pathological response groups. A complete pathological response was defined as no histopathological evidence of any residual invasive cancer cells in the breast or axillary lymph nodes. 39 patients showed complete pathological response, and 109 patients showed non-complete pathological response. Between enhancement profiles of MR CAD, plateau proportion of tumours was significantly correlated with the pathological response of tumours (mean proportion of plateau on complete pathological response group was 27%, p = 0.007). Conclusion: When plateau proportion of tumours is high, we can predict non-complete pathological response of neoadjuvant chemotherapy. Advances in knowledge: MR CAD can be a useful tool for the assessment of response to neoadjuvant chemotherapy and prediction of pathological results.
引用
收藏
页数:7
相关论文
共 46 条
[1]   Neoadjuvant therapy in breast cancer: Can we define its role? [J].
Aapro, MS .
ONCOLOGIST, 2001, 6 :36-39
[2]  
Abraham DC, 1996, CANCER, V78, P91, DOI 10.1002/(SICI)1097-0142(19960701)78:1<91::AID-CNCR14>3.0.CO
[3]  
2-2
[4]   Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI [J].
Balu-Maestro, C ;
Chapellier, C ;
Bleuse, A ;
Chanalet, I ;
Chauvel, C ;
Largillier, R .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 72 (02) :145-152
[5]   Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [J].
Bonadonna, G ;
Valagussa, P ;
Brambilla, C ;
Ferrari, L ;
Moliterni, A ;
Terenziani, M ;
Zambetti, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :93-100
[6]  
Buchholz TA, 2001, CANCER J, V7, P413
[7]   Neoadjuvant chemotherapy in breast cancer [J].
Charfare, H ;
Limongelli, S ;
Purushotham, AD .
BRITISH JOURNAL OF SURGERY, 2005, 92 (01) :14-23
[8]   Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy [J].
Chen, XM ;
Moore, MO ;
Lehman, CD ;
Mankoff, DA ;
Lawton, TJ ;
Peacock, S ;
Schubert, EK ;
Livingston, RB .
ACADEMIC RADIOLOGY, 2004, 11 (10) :1115-1124
[9]   Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI [J].
Cheung, YC ;
Chen, SC ;
Su, MY ;
See, LC ;
Hsueh, S ;
Chang, HK ;
Lin, YC ;
Tsai, CS .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) :51-58
[10]   TUMOR RECURRENCE VERSUS FIBROSIS IN THE IRRADIATED BREAST - DIFFERENTIATION WITH DYNAMIC GADOLINIUM-ENHANCED MR-IMAGING [J].
DAO, TH ;
RAHMOUNI, A ;
CAMPANA, F ;
LAURENT, M ;
ASSELAIN, B ;
FOURQUET, A .
RADIOLOGY, 1993, 187 (03) :751-755